首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   255220篇
  免费   32872篇
  国内免费   8955篇
耳鼻咽喉   1804篇
儿科学   3212篇
妇产科学   5643篇
基础医学   20606篇
口腔科学   2393篇
临床医学   21821篇
内科学   28488篇
皮肤病学   1817篇
神经病学   3657篇
特种医学   8237篇
外国民族医学   292篇
外科学   33706篇
综合类   34822篇
现状与发展   45篇
一般理论   3篇
预防医学   12177篇
眼科学   1166篇
药学   18601篇
  179篇
中国医学   7451篇
肿瘤学   90927篇
  2024年   891篇
  2023年   5348篇
  2022年   10251篇
  2021年   13581篇
  2020年   12587篇
  2019年   11391篇
  2018年   10797篇
  2017年   11415篇
  2016年   12277篇
  2015年   13889篇
  2014年   20092篇
  2013年   20249篇
  2012年   16360篇
  2011年   16778篇
  2010年   12486篇
  2009年   12488篇
  2008年   12709篇
  2007年   12253篇
  2006年   10711篇
  2005年   8935篇
  2004年   7390篇
  2003年   6142篇
  2002年   5227篇
  2001年   4757篇
  2000年   3915篇
  1999年   3331篇
  1998年   2852篇
  1997年   2553篇
  1996年   2122篇
  1995年   1898篇
  1994年   1634篇
  1993年   1291篇
  1992年   1171篇
  1991年   1027篇
  1990年   827篇
  1989年   758篇
  1988年   631篇
  1987年   548篇
  1986年   456篇
  1985年   605篇
  1984年   480篇
  1983年   347篇
  1982年   339篇
  1981年   317篇
  1980年   276篇
  1979年   183篇
  1978年   132篇
  1977年   107篇
  1976年   88篇
  1975年   56篇
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Background Inflammatory pseudotumors are characterized histopathologically by aggregates of inflammatory lymphocytes, plasma cells, neutrophils, and fibroblasts. We report a rare case of inflammatory pseudotumor involving both the conjunctiva and lung.Case A 58-year-old man with a 6-year history of pulmonary inflammatory pseudotumor was referred to our hospital for evaluation of conjunctival swelling in the left eye and bilateral iritis.Observations The subconjunctival tumor enlarged slowly, but regressed spontaneously. After partial resection of the subconjunctival and lung tumors, the presence was confirmed of aggregates of chronic inflammatory cells (lymphocytes, plasma cells, neutrophils, fibroblasts) without noncaseating epithelioid granuloma formation. Gene rearrangement testing ruled out malignancy. The patient was treated with oral corticosteroids for fever and primary biliary hepatic cirrhosis. Iritis signs subsided slightly in response to corticosteroids, but persisted. The temporal subconjunctival pseudotumor resolved without recurrence.Conclusions This case was compatible histopathologically with inflammatory pseudotumor, and is a rare case of simultaneous occurrence in the lung and conjunctiva. Jpn J Ophthalmol 2004;48:573–577 © Japanese Ophthalmological Society 2004  相似文献   
993.
目的:探讨亚甲蓝及粘弹剂在泪囊鼻腔吻合术中的应用价值。方法:对慢性泪囊炎患者21例21眼(其中6例6眼为小泪囊慢性泪囊炎)施行泪囊鼻腔吻合手术,术中应用亚甲蓝及粘弹剂。术后随访3mo~1a,观察手术疗效。结果:所有21眼中治愈19眼,好转2眼,治愈率90.5%,总有效率100.0%。其中6眼小泪囊慢性泪囊炎中治愈4眼,好转2眼。结论:亚甲蓝及粘弹剂在泪囊鼻腔吻合术中的应用可有效提高手术成功率,小泪囊慢性泪囊炎可作为泪囊鼻腔吻合术的手术适应证。  相似文献   
994.
A 14-year-old male presented with a T4 sigmoid adenocarcinoma, <10 colonic adenomas and multiple café-au-lait macules. Family history was not suggestive of a dominant hereditary form of colorectal cancer. Evaluation of the tumor revealed abnormal immunohistochemical staining of the PMS2 protein and high frequency microsatellite instability. Germline analysis identified biallelic PMS2 missense mutations. A new cancer syndrome caused by biallelic mutations in the mismatch repair genes, including PMS2, is now emerging and is characterized by café-au-lait macules, colonic polyps and a distinctive tumor spectrum.  相似文献   
995.
996.
Little is known about the participation rate of newly implemented colorectal cancer (CRC) screening programs in China. Our goals were to identify factors associated with nonparticipation for CRC screening in Songjiang District, Shanghai.We analyzed individuals included in an observational cohort study from 4 towns (Xin Qiao, She Shan, Mao Gang, and Zhong Shan) in Songjiang District. The participation rate was calculated for the CRC screening program based on a fecal immunochemical test and a risk assessment questionnaire between 2015 and 2017 inclusive.Of the 27,130 individuals eligible for inclusion in this study, 20,863 (76.9%) participated in CRC screening at least once during 2015 and 2017. The factors linked with nonparticipation were; being male (odds ratio [OR] 0.87, 95% confidence interval [CI] 0.82–0.93, P < .01), unmarried (OR 0.71, 95% CI 0.64–0.80, P < .01), having a high education level (middle school, OR 0.82, 95% CI 0.74–0.90, P < .01, high school or above, OR 0.64, 95% CI 0.57–0.73, P < .01), absence of chronic disease (OR 0.90, 95% CI 0.85–0.96, P < .01), and living in 2 out of the 4 towns covered (Xin Qiao, OR 0.72, 95% CI 0.66–0.78, P < .01, Zhong Shan, OR 0.29, 95% CI 0.26–0.31, P < .01).The current study revealed several associated factors with nonparticipation for the CRC screening in Songjiang district. These findings will help identify target populations that require an individualized approach to increase the participation rate.  相似文献   
997.
Background:Pancreatic extracorporeal shock wave lithotripsy (P-ESWL) is recommended as the first-line treatment for large pancreatic stones. While complications such as post-P-ESWL pancreatitis, bleeding, infection, steinstrasse, and perforation have been reported in the past 30 years, lung contusion has never been reported. The present case demonstrates lung contusion as a complication after P-ESWL.Methods:A 48-year-old man was admitted to our department due to painful chronic pancreatitis with pancreatic duct stones. Computed tomography revealed normal lungs. P-ESWL was performed. The shock wave head contacted with right upper quadrant and the path of shock wave was at a 45° angle to the ventral midline. After P-ESWL, multiple patchy high-density shadows in the lower lobe of right lung were found, which was normal before P-ESWL. The patient had no symptoms of lung injury.Results and Conclusion:Laboratory studies revealed elevated D-dimer from 0.33 to 0.74 ug/mL, which was consistent with abnormal clotting of lung contusion. Chest computed tomography showed slight pleural effusion. Considering the interval between 2 X-rays was only 3 hours, we inferred that lung contusion was related to P-ESWL. The patient displayed stable vital signs, therefore, no specific interventions were conducted. Three days after P-ESWL, endoscopic retrograde cholangiopancreatography was performed and the lung shadows were partially absorbed. Considering the location of shock wave head, it was possible to cause lung contusion in lower lobe of right lung. More than 10,000 P-ESWL therapeutic sessions had been performed in our center since 2010, and it is the first case about lung contusion as a complication. It is also the first report to describe lung contusion after P-ESWL. Although the patient was asymptomatic, it should raise awareness of clinicians.  相似文献   
998.
目的:本研究拟比较羟基喜树碱(喜素,HCPT)联合顺铂(DDP)与顺铂联合5-氟尿嘧啶(5-Fu)治疗晚期食管癌的近期疗效及不良反应。方法:对60例经病理证实的晚期食管癌初治患者给予联合化疗,随机分为DH组或DF。每组各30例,DH组病例应用HCPT(6mg/m2d1~3)加DDP(25mg/m2d1~3),DF组病例应用5-Fu(750mg/m2d1~5)加DDP(25mg/m2d1~3),21d为一个周期,每例患者治疗少于2个周期。结果:DH组患者总有效率为46.7%,中位缓解期4.2个月;DF组患者总有效率为50.0%,中位生存期3.8个月,两组有效率比较差异无显著性。最常见的毒副反应为骨髓抑制和恶心、呕吐,DH组20.0%(6/30)出现Ⅲ~Ⅳ度白细胞下降,DF组13.3%(4/30)出现Ⅲ~Ⅳ度白细胞下降,二者比较差异无统计学意义,DH组和DF的Ⅲ Ⅳ度恶心、呕吐反应发生率分别为33.3%和30.0%,差别无统计学意义。DH组腹泻发生率26.7%,但可耐受。结论:DH与DF方案相比,疗效相似,不良反应虽有所不同,但毒性可以耐受,是对晚期食管癌有效的化疗方案之一。  相似文献   
999.
血必净对大鼠肝缺血-再灌注后急性肺损伤的保护作用   总被引:1,自引:0,他引:1  
马巍  杨季红  马静  赵丹宁 《河北医药》2008,30(2):142-143
目的观察肝脏缺血-再灌注后急性肺损伤的发病机制及血必净对其的干预作用。方法将健康雄性Wistar大鼠90只随机分3组:假手术组(SOG组)30只,缺血再灌注组(I/R组)30只,血必净组(XBJ组)组30只。XBJ组术前3d经尾静脉注射血必净注射液5ml·kg-1·d-1。于再灌注6h、12h、24h各组分别随机选取10只大鼠进行标本检测:观察大鼠肺脏组织病理切片;取新鲜肺组织测定湿/干重比(W/D)、肺组织髓过氧化物酶(MPO)含量,取动脉血检测血气分析(PaO2)。结果XBJ组较I/R组在相同时相点的肺脏病理改变较轻,MPO含量显著降低(P<0.01);W/D显著降低(P<0.01);PaO2升高(P<0.05)。结论血必净注射液对肝脏缺血-再灌注后急性肺损伤具有保护作用,该作用与抑制中性粒细胞在肺内集聚、减少氧自由基的产生有关。  相似文献   
1000.
孙宝信  杜新生  薛承岩 《河北医药》2008,30(9):1287-1288
目的 了解监测腹液中端粒酶活性(TA)用于诊断腹腔转移癌、评价腹腔化疗疗效及预后的临床价值.方法 应用端粒末端重复序列扩增-杂交-酶联免疫技术检测腹液中TA,分析腹腔转移癌患者腹腔化疗前后腹液中TA结果的变化与预后的关系.结果 腹腔转移癌腹液中TA的阳性结果(56/68)显著性高于良性腹水患者(2/33)(P<0.01),其阳性率也显著高于CEA、细胞学检测结果(P<0.01);化疗有效者的阳性结果(10/37)明显低于化疗无效者(28/31) (P<0.01),且化疗后TA阳性者6~18个月的生存人数显著性低于指标阴性者(P<0.01或P<0.05).结论 检测腹腔化疗前后腹液中TA对协助诊断腹腔转移癌、评价腹腔化疗疗效及判断预后都有较高的应用价值.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号